During the past decade, Ospedali Riuniti Foggia conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 7 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedali Riuniti Foggia" #1 sponsor was "University of Foggia" with 7 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen-Cilag S.p.A." with 3 trials sponsored and "Ospedali Riuniti di Foggia" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedali Riuniti Foggia" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator and "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Ospedali Riuniti Foggia" are "Leukemia" (4 trials), "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Coronary Artery Disease" (2 trials) and "Coronary Artery Restenosis" (2 trials). Many other conditions were trialed in "Ospedali Riuniti Foggia" in a lesser frequency.

Most popular intervention types in "Ospedali Riuniti Foggia" are "Drug" (27 trials), "Device" (8 trials), "Procedure" (8 trials), "Radiation" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "mitoxantrone hydrochloride" (4 trials), "radiation therapy" (4 trials), "Placebo" (3 trials), "allogeneic bone marrow transplantation" (3 trials) and "autologous bone marrow transplantation" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedali Riuniti Foggia" are 49 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedali Riuniti Foggia". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Ospedali Riuniti Foggia, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedali Riuniti Foggia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Ospedali Riuniti Foggia has several departments that took part in Clinical trials: "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria" - 17 trials, "Ospedali Riuniti - S.C. Di Cardiologia Univ.-Utic" - 10 trials, "Università degli studi di Foggia, ospedale pneumologico D'Avanzo, unità operativa di malattie dell'apparato respiratorio" - 2 trials